Metacon publishes interim report for Q3 2024
STOCKHOLM, Nov. 19, 2024 /PRNewswire/ — In the third quarter, we were pleased to announce that we had entered into an agreement for the sale and delivery of a 30 MW electrolysis plant to Motor Oil, in Greece. It is a breakthrough in our strategy to become a leading manufacturer and supplier in
Crypto Exchange OrangeX Provides Advanced Efficiency to 3.5 Million Users with Sharding Upgrade
VICTORIA, Seychelles, Nov. 19, 2024 /PRNewswire/ — OrangeX, a trusted cryptocurrency exchange since 2021, proudly announces the integration of advanced database sharding technology, a tangible upgrade that boosts single-point transaction performance by over 50% and raises overall throughput t
ZINZINO AB (PUBL.): INTERIM REPORT THIRD QUARTER 2024
GOTHENBURG, Sweden, Nov. 19, 2024 /PRNewswire/ — CONTINUED STRONG GROWTH IN THE THIRD QUARTER Revenues in the third quarter of 2024 amounted to SEK 532.8 (436.9) million, corresponding to 22% (25%) growth compared to the corresponding period last year. In local currencies, revenues increased b
GiG Software Plc (“GiG” or the “Company”): Partnership Extension
Extension of agreement with Betsson enables expansion into new and regulated markets STOCKHOLM, Nov. 19, 2024 /PRNewswire/ — GiG Software Plc (First North: GiG SDB), a leading B2B iGaming technology company, is pleased to announce that it has extended its existing partnership with Betsson Gro
50 years of developing Brazil-China trade
BEIJING, Nov. 18, 2024 /PRNewswire/ — A news report from chinadaily.com.cn: Brazil and China share a successful relationship which is deeply rooted in complementarities, mutual respect and mutual benefit. What we see today, especially after the record $105 billion bilateral trade in 2023, is
Neurizon’s NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study
Highlights: Positive preclinical results in human in vitro iPSC Motor Neuron models of Amyotrophic Lateral Sclerosis (ALS) Neurizon’s lead drug NUZ-001 and its major active metabolite significantly and dose-dependently prevented the aggregation of TAR DNA-binding protein 43 (TDP-43) by ~50% an
Cboe Conducts First European Retail Investor Survey; Indicates Strong Demand for European Equity Options and Trusted Financial Education
Survey suggests strong interest in exchange-traded equity options from both current retail European derivatives investors and non-derivatives investors European retail investors’ primary motivations in options trading include capital protection and hedging Investors overall said they want m
APRIL Group Awards Scholarships to 250 High School and Vocational Students across Its Five Operational Districts in Pangkalan Kerinci, Pelalawan in Indonesia
SINGAPORE, Nov. 19, 2024 /PRNewswire/ — APRIL Group, a member of the RGE group of companies, has reaffirmed its commitment to inclusive progress as part of its APRIL2030 transformation strategy by awarding scholarships to 250 high school and vocational students from its five operational distri
“Beautiful China, I am an Actor” 2024 Business Climate Action Cases Released at COP29, Demonstrating Corporate Climate Responsibility
BAKU, Azerbaijan, Nov. 19, 2024 /PRNewswire/ — At a critical moment for global climate action, Chinese corporates are responding to the theme of COP29, “Enhancing Ambition, Implementing Action,” with concrete actions. On November 18th, the conference for the “Beautiful China
Essity expands its athletics tape production in France
STOCKHOLM, Nov. 19, 2024 /PRNewswire/ — Hygiene and health company Essity is expanding its production of athletics tape by investing in a new production line for Leukotape K. The investment enables a significant increase in production capacity to meet the growing global demand. Leukotape K i